Cargando…

Should C-Reactive Protein Be a Target of Therapy?

Detalles Bibliográficos
Autores principales:	Oh, Jisun, Teoh, Hwee, Leiter, Lawrence A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Diabetes and Cardiovascular Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632154/ https://www.ncbi.nlm.nih.gov/pubmed/21525448 http://dx.doi.org/10.2337/dc11-s211

Ejemplares similares

Should A1C Targets Be Individualized for All People With Diabetes?: Arguments for and against
por: Teoh, Hwee, et al.
Publicado: (2011)

Postprandial Hyperglycemia and Glycemic Variability: Should we care?
por: Standl, Eberhard, et al.
Publicado: (2011)

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
por: Versari, Daniele, et al.
Publicado: (2009)

Antiplatelet Therapy for Every Diabetic Person?
por: Nicolucci, Antonio, et al.
Publicado: (2011)

Getting to the “Heart” of the Matter on Diabetic Cardiovascular Disease: “Thanks for the Memory”
por: Cefalu, William T., et al.
Publicado: (2016)

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes
por: Davidson, Jaime A., et al.
Publicado: (2009)

A Summary of the ADVANCE Trial
por: Heller, Simon R.
Publicado: (2009)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
por: Kassem, Sameer A., et al.
Publicado: (2009)

Is Hyperglycemia a Cardiovascular Risk Factor?
por: Pistrosch, Frank, et al.
Publicado: (2011)

Heart in Diabetes: A Microvascular Disease
por: Laakso, Markku
Publicado: (2011)

Heart in Diabetes: Not Only a Macrovascular Disease
por: Stratmann, Bernd, et al.
Publicado: (2011)

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
por: Gori, Mauro, et al.
Publicado: (2016)

Hypoglycemia and Cardiovascular Risks
por: Frier, Brian M., et al.
Publicado: (2011)

Shifting the Disease Management Paradigm From Glucose: What are the pros?
por: Stirban, Alin, et al.
Publicado: (2009)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
por: Bianchi, Cristina, et al.
Publicado: (2009)

Glucose Control and Cardiovascular Disease: Is it important? No
por: Conget, Ignacio, et al.
Publicado: (2009)

The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
por: Schnell, Oliver, et al.
Publicado: (2009)

Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes: Understanding and implementing the International Diabetes Federation guidelines
por: Gallwitz, Baptist
Publicado: (2009)

Shifting the Disease Management Paradigm From Glucose: What are the cons?
por: Hanefeld, Markolf, et al.
Publicado: (2009)

Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts
por: Floegel, Anna, et al.
Publicado: (2017)

Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
por: Potempa, Lawrence A., et al.
Publicado: (2022)

Occupational Exposure to PM(2.5) and Incidence of Ischemic Heart Disease: Longitudinal Targeted Minimum Loss-based Estimation
por: Brown, Daniel M., et al.
Publicado: (2015)

Milk intake, lactase persistence genotype, plasma proteins and risks of cardiovascular events in the Swedish general population
por: Zhang, Shunming, et al.
Publicado: (2023)

C-reactive Protein Is a Diagnostic Tool for Postoperative Infection in Orthopaedics
por: Shetty, Saiganesh, et al.
Publicado: (2022)

C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
por: Park, Jin Joo, et al.
Publicado: (2022)

Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2011)

C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
por: Ries, Wolfgang, et al.
Publicado: (2021)

C-reactive protein and coronary atheroma regression following statin therapy: A meta-regression of randomized controlled trials
por: Gao, Darui, et al.
Publicado: (2022)

Serial C-reactive Protein Monitoring in Prosthetic Joint Infection: A Powerful Predictor or Potentially Pointless?
por: Ghani, Rafia, et al.
Publicado: (2020)

C-reactive protein and the neutrophil-to-lymphocyte ratio on admission predicting bacteraemia with COVID-19
por: Ueda, Yoshitaka, et al.
Publicado: (2023)

A UNIQUE CASE OF PURE ASYMPTOMATIC PERICARDITIS IN COVID-19
por: ADAM, A., et al.
Publicado: (2022)

Glycaemic Effects of Non-statin Lipid-Lowering Therapies
por: Collins, Patrick D., et al.
Publicado: (2016)

The relation between socioeconomic status and short-term mortality after acute myocardial infarction persists in the elderly: results from a nationwide study
por: van Oeffelen, Aloysia A. M., et al.
Publicado: (2012)

Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table
por: Doehner, Wolfram, et al.
Publicado: (2019)

Prognostic value of C-reactive protein in adults with congenital heart disease
por: Geenen, Laurie W, et al.
Publicado: (2021)

No Reduction of Atherosclerosis in C-reactive Protein (CRP)-deficient Mice
por: Teupser, Daniel, et al.
Publicado: (2011)

Twenty-year trajectories of cardio-metabolic factors among people with type 2 diabetes by dementia status in England: a retrospective cohort study
por: Lai, Heidi T. M., et al.
Publicado: (2023)

MASSIVE PULMONARY EMBOLISM IN COVID-19 PNEUMONIA DIAGNOSED WITH POCUS
por: ADAM, A., et al.
Publicado: (2022)

A FEBRILE CRISIS: MONOMORPHIC VENTRICULAR TACHYCARDIA IN A STRUCTURALLY INTACT HEART
por: CACDAC, ROBERT, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND COVID-19 A DEADLY COMBINATION: A RETROSPECTIVE COHORT STUDY IN A LARGE TERTIARY CARE TEACHING HOSPITAL
por: AMANZAI, ABASIN, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_va7sre1h3gqvl21fgiv480fjb9